Viewing Study NCT02880293

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:16 AM
Ignite Modification Date: 2026-02-20 @ 10:57 PM
Study NCT ID: NCT02880293
Status: COMPLETED
Last Update Posted: 2024-12-06
First Post: 2016-08-23
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hematologic Malignancy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None transplant conditioning View
None KIR/HLA based haploidentical donor selection View
None allogeneic hematopoietic cell transplantation View